Ilan S Schwartz1, Nelesh P Govender2, Craig Corcoran3, Sipho Dlamini4, Hans Prozesky5, Rosie Burton5, Marc Mendelson4, Jantjie Taljaard5, Rannakoe Lehloenya6, Greg Calligaro7, Robert Colebunders8, Chris Kenyon9. 1. Departments of Medical Microbiology and Internal Medicine, Faculty of Health Sciences, College of Medicine, University of Manitoba, Winnipeg, Canada Department of Epidemiology and Social Medicine, Faculty of Health Sciences, University of Antwerp, Belgium. 2. National Institute for Communicable Diseases-Centre for Opportunistic, Tropical and Hospital Infections, National Health Laboratory Service, Sandringham Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. 3. Ampath National Laboratory Services, Centurion. 4. Division of Infectious Diseases & HIV Medicine, Department of Medicine, University of Cape Town. 5. Division of Infectious Diseases, Department of Medicine, Stellenbosch University. 6. Division of Dermatology, Department of Medicine, University of Cape Town. 7. UCT Lung Institute, University of Cape Town, South Africa. 8. Department of Epidemiology and Social Medicine, Faculty of Health Sciences, University of Antwerp, Belgium Clinical Sciences Unit, Institute of Tropical Medicine, Antwerp, Belgium. 9. Division of Infectious Diseases & HIV Medicine, Department of Medicine, University of Cape Town Clinical Sciences Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Abstract
BACKGROUND: We describe the geographic distribution, clinical characteristics, and management of patients with disease caused by Emmonsia sp., a novel dimorphic fungal pathogen recently described in South Africa. METHODS: We performed a multicenter, retrospective chart review of laboratory-confirmed cases of emmonsiosis diagnosed across South Africa from January 2008 through February 2015. RESULTS: Fifty-four patients were diagnosed in 5/9 provinces. Fifty-one patients (94%) were human immunodeficiency virus coinfected (median CD4 count 16 cells/µL [interquartile range, 6-40]). In 12 (24%) of these, antiretroviral therapy had been initiated in the preceding 2 months. All patients had disseminated disease, most commonly involving skin (n = 50/52, 96%) and lung (n = 42/48, 88%). Yeasts were visualized on histopathologic examination of skin (n = 34/37), respiratory tissue (n = 2/4), brain (n = 1/1), liver (n = 1/2), and bone marrow (n = 1/15). Emmonsia sp. was cultured from skin biopsy (n = 20/28), mycobacterial/fungal and aerobic blood culture (n = 15/25 and n = 9/37, respectively), bone marrow (n = 12/14), lung (n = 1/1), lymph node (n = 1/1), and brain (n = 1/1). Twenty-four of 34 patients (71%) treated with amphotericin B deoxycholate, 4/12 (33%) treated with a triazole alone, and none of 8 (0%) who received no antifungals survived. Twenty-six patients (48%) died, half undiagnosed. CONCLUSIONS: Disseminated emmonsiosis is more widespread in South Africa and carries a higher case fatality rate than previously appreciated. Cutaneous involvement is near universal, and skin biopsy can be used to diagnose the majority of patients.
BACKGROUND: We describe the geographic distribution, clinical characteristics, and management of patients with disease caused by Emmonsia sp., a novel dimorphic fungal pathogen recently described in South Africa. METHODS: We performed a multicenter, retrospective chart review of laboratory-confirmed cases of emmonsiosis diagnosed across South Africa from January 2008 through February 2015. RESULTS: Fifty-four patients were diagnosed in 5/9 provinces. Fifty-one patients (94%) were human immunodeficiency virus coinfected (median CD4 count 16 cells/µL [interquartile range, 6-40]). In 12 (24%) of these, antiretroviral therapy had been initiated in the preceding 2 months. All patients had disseminated disease, most commonly involving skin (n = 50/52, 96%) and lung (n = 42/48, 88%). Yeasts were visualized on histopathologic examination of skin (n = 34/37), respiratory tissue (n = 2/4), brain (n = 1/1), liver (n = 1/2), and bone marrow (n = 1/15). Emmonsia sp. was cultured from skin biopsy (n = 20/28), mycobacterial/fungal and aerobic blood culture (n = 15/25 and n = 9/37, respectively), bone marrow (n = 12/14), lung (n = 1/1), lymph node (n = 1/1), and brain (n = 1/1). Twenty-four of 34 patients (71%) treated with amphotericin B deoxycholate, 4/12 (33%) treated with a triazole alone, and none of 8 (0%) who received no antifungals survived. Twenty-six patients (48%) died, half undiagnosed. CONCLUSIONS: Disseminated emmonsiosis is more widespread in South Africa and carries a higher case fatality rate than previously appreciated. Cutaneous involvement is near universal, and skin biopsy can be used to diagnose the majority of patients.
Authors: Tsidiso G Maphanga; Erika Britz; Thokozile G Zulu; Ruth S Mpembe; Serisha D Naicker; Ilan S Schwartz; Nelesh P Govender Journal: J Clin Microbiol Date: 2017-03-29 Impact factor: 5.948
Authors: Karolina Dukik; Jose F Muñoz; Yanping Jiang; Peiying Feng; Lynne Sigler; J Benjamin Stielow; Joanna Freeke; Azadeh Jamalian; Bert Gerrits van den Ende; Juan G McEwen; Oliver K Clay; Ilan S Schwartz; Nelesh P Govender; Tsidiso G Maphanga; Christina A Cuomo; Leandro F Moreno; Chris Kenyon; Andrew M Borman; Sybren de Hoog Journal: Mycoses Date: 2017-02-07 Impact factor: 4.377
Authors: Tsidiso G Maphanga; Monica Birkhead; José F Muñoz; Mushal Allam; Thokozile G Zulu; Christina A Cuomo; Ilan S Schwartz; Arshad Ismail; Serisha D Naicker; Ruth S Mpembe; Craig Corcoran; Sybren de Hoog; Chris Kenyon; Andrew M Borman; John A Frean; Nelesh P Govender Journal: J Clin Microbiol Date: 2020-02-24 Impact factor: 5.948
Authors: Ilan S Schwartz; Barbra Lerm; J Claire Hoving; Chris Kenyon; William G Horsnell; W Joan Basson; Patricia Otieno-Odhiambo; Nelesh P Govender; Robert Colebunders; Alfred Botha Journal: Emerg Infect Dis Date: 2018-02 Impact factor: 6.883
Authors: George R Thompson; Thuy Le; Ariya Chindamporn; Carol A Kauffman; Ana Alastruey-Izquierdo; Neil M Ampel; David R Andes; Darius Armstrong-James; Olusola Ayanlowo; John W Baddley; Bridget M Barker; Leila Lopes Bezerra; Maria J Buitrago; Leili Chamani-Tabriz; Jasper F W Chan; Methee Chayakulkeeree; Oliver A Cornely; Cao Cunwei; Jean-Pierre Gangneux; Nelesh P Govender; Ferry Hagen; Mohammad T Hedayati; Tobias M Hohl; Grégory Jouvion; Chris Kenyon; Christopher C Kibbler; Nikolai Klimko; David C M Kong; Robert Krause; Low Lee Lee; Graeme Meintjes; Marisa H Miceli; Peter-Michael Rath; Andrej Spec; Flavio Queiroz-Telles; Ebrahim Variava; Paul E Verweij; Ilan S Schwartz; Alessandro C Pasqualotto Journal: Lancet Infect Dis Date: 2021-08-06 Impact factor: 71.421
Authors: Ilan S Schwartz; Chris Kenyon; Peiying Feng; Nelesh P Govender; Karolina Dukik; Lynne Sigler; Yanping Jiang; J Benjamin Stielow; José F Muñoz; Christina A Cuomo; Alfred Botha; Alberto M Stchigel; G Sybren de Hoog Journal: PLoS Pathog Date: 2015-11-19 Impact factor: 6.823
Authors: Ilan S Schwartz; Chris Kenyon; Rannakoe Lehloenya; Saskya Claasens; Zandile Spengane; Hans Prozesky; Rosie Burton; Arifa Parker; Sean Wasserman; Graeme Meintjes; Marc Mendelson; Jantjie Taljaard; Johann W Schneider; Natalie Beylis; Bonnie Maloba; Nelesh P Govender; Robert Colebunders; Sipho Dlamini Journal: Open Forum Infect Dis Date: 2017-08-25 Impact factor: 3.835